National Guidelines for the Management of Lupus Nephritis in Saudi Arabia
Annals of Rheumatology and Autoimmunity · 2022
DOI: 10.4103/ara.ara_12_22 ↗Kurz gefasst
Leitlinie in der Zeitschrift Annals of Rheumatology and Autoimmunity, 2022. Verfasst von Hanan M Al Al Rayes und 8 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Context
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that can affect all organs and cause considerable morbidity and mortality. The estimated prevalence of SLE in the central region of Saudi Arabia is 19.28/100,000 individuals. Approximately half of those will eventually develop clinically significant renal disease. Therefore, screening for renal involvement is essential for early diagnosis and optimal disease management.
Aims
This study aims to develop a pathway that can facilitate the early diagnosis and management of lupus glomerulonephritis in the Kingdom of Saudi Arabia. Methodology: The Saudi Society of Rheumatology in collaboration with the Saudi Society of Nephrology and Transplantation and under the supervision of the Saudi Commission for Health Specialties formed a committee involving rheumatologists, nephrologists, and a renal pathologist. Multiple workshops were conducted to adapt the 2019 Update of the Joint European League against Rheumatism and European Renal Association–European Dialysis and Transplant Association recommendations for the management of SLE, as well as The Kidney Disease: Improving Global Outcome 2020 using the ADAPTE process.
Results
This document includes recommendations related to screening for renal involvement, renal pathology and classification, initial and subsequent therapy for lupus nephritis (LN), the treatment of refractory and relapsing LN, and the management of advanced renal disease. Recommendations concerning pregnancy and postpartum care are also included.
Conclusion
We developed a guideline for the management of adults with LN based on recommendations developed elsewhere. This guideline was adapted to the local context of our health-care system.
Zitieren
APA
Rayes, H. M. A. A., Alfaris, H., Alkhowaiter, M., Alghanim, K. K., Aljohani, R., Alkhalaf, A., Abdulaziz, S., Aljohani, T. E., & Alsuwaida, A. (2022). National Guidelines for the Management of Lupus Nephritis in Saudi Arabia. Annals of Rheumatology and Autoimmunity. https://doi.org/10.4103/ara.ara_12_22
Vancouver
Rayes HMAA, Alfaris H, Alkhowaiter M, Alghanim KK, Aljohani R, Alkhalaf A, et al. National Guidelines for the Management of Lupus Nephritis in Saudi Arabia. Annals of Rheumatology and Autoimmunity. 2022. doi:10.4103/ara.ara_12_22
BibTeX
@article{Rayes2022,
author = {Rayes, Hanan M Al Al and Alfaris, Huda and Alkhowaiter, Mohammad and Alghanim, Khawla K and Aljohani, Roaa and Alkhalaf, Abdulaziz and Abdulaziz, Sultana and Aljohani, Tariq E and Alsuwaida, Abdulkareem},
title = {National Guidelines for the Management of Lupus Nephritis in Saudi Arabia},
journal = {Annals of Rheumatology and Autoimmunity},
year = {2022},
doi = {10.4103/ara.ara_12_22}
}
EUVIMED